‘We’ve Actually Got Millions of People to Think About It’: What We Heard This Week

: They scour the most important new findings across the journals, curating and distilling the new information for the benefit of our readers. Our writers also attend roughly 75 medical conferences a year in the U.S. and abroad to bring you the most relevant meeting coverage across all the major specialties. “,”affiliation”:””,”credential”:””,”url_identifier”:”mt9773″,”avatar_url”:””,”avatar_alt_text”:”MedPage Today Staff”,”twitter”:””,”links”:{“signal”:””,”bluesky”:””,”website”:””,”linkedin”:””,”muckrack”:””},”has_author_page”:1,”byline”:null,”full_name”:”MedPage Today Staff”,”title”:””,”url”:”https:\/\/www.medpagetoday.com\/people\/mt9773\/medpage-today staff”,”bluesky”:””}]” categoryimage=”https://assets.medpagetoday.net/media/images/articles/What_We_Heard_subsicon_blue_200px.png” categoryimagealt=”What We Heard This Week”/>

“By the actions of the ADA, we’ve actually got millions of people to think about it.” — Steven Kahn, MBChB, editor-in-chief of Diabetes Care, on being kicked out of the American Diabetes Association (ADA) meeting after distributing an editorial criticizing Trump administration changes to U.S. biomedical research.

“The field has really exploded.” — Anthony Maresso, PhD, of Baylor College of Medicine, on how wastewater surveillance to monitor pathogens has risen in prominence.

“The associations are pretty striking.” — Aparna Kamat, MD, of Houston Methodist Hospital, on the growing body of evidence linking GLP-1 drugs to a lower risk of multiple cancers.

“I would consider him lucky, and somewhat of a medical mystery.” — Evan Cohen, MD, of Northwell Health’s Northern Westchester Hospital in New York, discussing a case study involving a man who said he swallowed a toothbrush 20 years ago on a bet.

“This is a time for physicians to lead, not to wait.” — Avani Patel, MD, MHA, of Jackson, Mississippi, discussing the need to get ahead of artificial intelligence “creep” in medicine.

“It is a serious medication, and you do have to be careful when you take it.” — Raman Madan, MD, of Northwell Health in New York, discussing a popular trend of microdosing isotretinoin (Accutane) to reduce side effects.

“It is a virus that infects many different types of cells.” — Bridgette Jeanne Billioux, MD, of the National Institute of Neurological Disorders and Stroke, on neurologic symptoms that persisted in Ebola survivors more than 7 years post-infection.

“Unless there is a clear indication … these medications should not be given routinely.” — Sarina Sahetya, MD, of Johns Hopkins School of Medicine in Baltimore, on a trial showing two common mucoactive agents may do more harm than good for critically ill patients with acute respiratory failure.

“This does need to get done, but we’re not there yet.” — Eli Freiman, MD, a American Medical Association delegate from the Massachusetts Medical Society, during a debate about whether to mandate universal newborn screening for congenital cytomegalovirus.